Published in N Engl J Med on November 29, 1973
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (1997) 14.41
Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med (1997) 12.08
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Formation of a covalent complex between the 80,000-dalton adenovirus terminal protein and 5'-dCMP in vitro. Proc Natl Acad Sci U S A (1981) 3.55
Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes. Int J Clin Pract (2010) 2.75
Complementation of the temperature-sensitive defect in H5ts125 adenovirus DNA replication in vitro. Proc Natl Acad Sci U S A (1979) 2.70
Separation of the adenovirus terminal protein precursor from its associated DNA polymerase: role of both proteins in the initiation of adenovirus DNA replication. Proc Natl Acad Sci U S A (1982) 2.65
Studies of the mechanism of enhancement of human adenovirus infection in monkey cells by simian virus 40. J Virol (1972) 2.55
Psychiatric morbidity and compulsory admission among UK-born Europeans, Afro-Caribbeans and Asians in central Manchester. Br J Psychiatry (1993) 2.52
Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol (1998) 2.48
The effect of aphidicolin on adenovirus DNA synthesis. Nucleic Acids Res (1979) 2.47
The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses. J Virol (1998) 2.45
The problem of associating coagulase-negative staphylococci with disease. Ann N Y Acad Sci (1965) 2.43
Human calcitonin in the treatment of Paget's bone disease. Lancet (1971) 2.37
Partner's influence on patient preference for treatment in early prostate cancer. BJU Int (2003) 2.33
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Synthesis and assembly of adenovirus 2. I. Polypeptide synthesis, assembly of capsomeres, and morphogenesis of the virion. Virology (1969) 2.27
Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology (1989) 2.24
Role of cytoplasmic vacuoles in varicella-zoster virus glycoprotein trafficking and virion envelopment. J Virol (1988) 2.22
The AKT kinase is activated in multiple myeloma tumor cells. Blood (2001) 2.20
Varicella-zoster virus: isolation and propagation in human melanoma cells at 36 and 32 degrees C. Infect Immun (1978) 2.15
Endocytosis and recycling of varicella-zoster virus Fc receptor glycoprotein gE: internalization mediated by a YXXL motif in the cytoplasmic tail. J Virol (1997) 2.14
Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science (1985) 2.10
Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med (1990) 2.09
Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J Virol (1985) 2.09
DAP kinase activates a p19ARF/p53-mediated apoptotic checkpoint to suppress oncogenic transformation. Nat Cell Biol (2001) 2.09
American Academy of Pediatrics. Committee on Adolescence. Contraception in adolescents. Pediatrics (1999) 2.06
Is alignment within 8 prism diopters of orthotropia a successful outcome for infantile esotropia surgery? Arch Ophthalmol (1996) 2.06
Temperature-sensitive replication of H5ts125 adenovirus DNA in vitro. Proc Natl Acad Sci U S A (1978) 2.02
Primary Epstein-Barr-virus infections in acute neurologic diseases. N Engl J Med (1975) 2.02
Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol (1998) 2.00
Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. Virology (2000) 1.99
Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J Virol (1994) 1.99
Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun (1983) 1.95
Should baseline PSA testing be performed in men aged 40 to detect those aged 50 or less who are at risk of aggressive prostate cancer? S Afr Med J (2011) 1.95
British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med (2003) 1.94
Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect against anthrax. Infect Immun (2000) 1.93
Assessment of health needs and willingness to utilize health care resources of adolescents in a suburban population. J Pediatr (1983) 1.90
Elongation of primed DNA templates by eukaryotic DNA polymerases. Proc Natl Acad Sci U S A (1980) 1.90
Cardiopulmonary resuscitation directives on admission to intensive-care unit: an international observational study. Lancet (2001) 1.90
Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte. J Virol (1995) 1.89
Precipitants of brain infarction. Roles of preceding infection/inflammation and recent psychological stress. Stroke (1996) 1.86
Increased tumorigenicity of fibronectin receptor deficient Chinese hamster ovary cell variants. Cancer Res (1991) 1.86
Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J Virol (1992) 1.81
Multiple rounds of adenovirus DNA synthesis in vitro. Proc Natl Acad Sci U S A (1981) 1.79
Trial of Whooping-cough Vaccine. Br Med J (1945) 1.76
Intermediates in the synthesis of type 2 adenovirus deoxyribonucleic acid. J Virol (1971) 1.75
Ampicillin levels in sputum, serum, and saliva. Thorax (1970) 1.73
Rocuronium: high risk for anaphylaxis? Br J Anaesth (2001) 1.72
The synthesis of glycoproteins in human melanoma cells infected with varicella-zoster virus. Virology (1980) 1.72
Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect (2007) 1.72
Biliary atresia and reovirus type 3 infection. N Engl J Med (1982) 1.72
Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology (1995) 1.72
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. AIDS (1994) 1.70
Blood volume replacement in acute anaphylactic cardiovascular collapse related to anaesthesia. Br J Anaesth (1977) 1.70
Protein-protein interactions between adenovirus DNA polymerase and nuclear factor I mediate formation of the DNA replication preinitiation complex. J Biol Chem (1990) 1.70
Variation on a theme by Fenner: the pathogenesis of chickenpox. Pediatrics (1981) 1.69
Interaction of an adenovirus E3 14.7-kilodalton protein with a novel tumor necrosis factor alpha-inducible cellular protein containing leucine zipper domains. Mol Cell Biol (1998) 1.68
Cell-free varicella-zoster virus in cultured human melanoma cells. J Gen Virol (1979) 1.64
Synthesis of type 2 adenovirus DNA in the presence of cycloheximide. J Virol (1973) 1.62
Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J Virol (1998) 1.62
A pilot qualitative analysis of the psychosocial factors which drive young people to decline chlamydia testing in the UK: implications for health promotion and screening. Int J STD AIDS (2010) 1.60
Isolation of proteins involved in the replication of adenoviral DNA in vitro. Cold Spring Harb Symp Quant Biol (1983) 1.60
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol (1986) 1.59
Noninvasive quantification of brain edema and the space-occupying effect in rat stroke models using magnetic resonance imaging. Stroke (2004) 1.59
The British HIV Association/British Association for Sexual Health and HIV Position Statement on pre-exposure prophylaxis in the UK. Int J STD AIDS (2012) 1.59
Replication of adenovirus type 2 DNA in vitro. Proc Natl Acad Sci U S A (1977) 1.58
Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system. J Virol (1993) 1.58
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Immunohematologic characteristics of infection-associated cerebral infarction. Stroke (1991) 1.55
Adenovirus DNA replication in soluble extracts of infected cell nuclei. Cold Spring Harb Symp Quant Biol (1979) 1.53
The in vitro replication of adenovirus DNA. Curr Top Microbiol Immunol (1984) 1.53
Consensus: varicella-zoster infections in pregnancy and the perinatal period. Pediatr Infect Dis J (1990) 1.53
Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. J Virol (2001) 1.53
Mouse adenovirus type 1 causes a fatal hemorrhagic encephalomyelitis in adult C57BL/6 but not BALB/c mice. J Virol (1995) 1.53
Transient and permanent resolution of ischemic lesions on diffusion-weighted imaging after brief periods of focal ischemia in rats : correlation with histopathology. Stroke (2000) 1.52
Atherosclerosis: current concepts on pathogenesis and interventional therapies. Ann Neurol (1989) 1.51
Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology (2001) 1.50
Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol (1978) 1.50
Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J Virol (1997) 1.50
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology (1984) 1.49
Site-directed mutagenesis of herpesvirus glycoprotein phosphorylation sites by recombination polymerase chain reaction. PCR Methods Appl (1992) 1.49
Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J Virol (1996) 1.49
Nanometal surface energy transfer in optical rulers, breaking the FRET barrier. J Am Chem Soc (2005) 1.48
Serine protein kinase associated with varicella-zoster virus ORF 47. Virology (1992) 1.48
Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects. N Engl J Med (1976) 1.46
Effects of the adenovirus H5ts125 and H5ts107 DNA binding proteins on DNA replication in vitro. Virology (1983) 1.46
Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex. Virology (1994) 1.46
Does bilateral internal thoracic artery grafting increase surgical risk in diabetic patients? Ann Thorac Surg (1998) 1.45
Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters. HIV Med (2010) 1.45
Adenovirus isolates from urine of patients with acquired immunodeficiency syndrome. Lancet (1983) 1.45
Bidirectional replication of adenovirus type 2 DNA. J Virol (1976) 1.44
Increase in diagnosed newly acquired hepatitis C in HIV-positive men who have sex with men across London and Brighton, 2002-2006: is this an outbreak? Sex Transm Infect (2007) 1.44
Pyomyositis in an adolescent female athlete. J Pediatr Surg (1995) 1.43
Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc Natl Acad Sci U S A (1999) 1.42
Hypermagnesemic pseudocoma. Arch Intern Med (1993) 1.42
Promoters selected from random DNA sequences. Proc Natl Acad Sci U S A (1986) 1.41